Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 200 of 1,261

  1. US 11629174

    Cryptic metabolites and method for activating silent biosynthetic gene clusters in actinomycete bacteria

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  2. IT 202100026282

    Surnatante fermentato e composizioni postbiotiche utili nella prevenzione e nel trattamento di malattie cardiovascolari

    ALFASIGMA SPA [IT] · Granted Apr 13, 2023 · Expires Apr 8, 2043

    granted

  3. US 11622975

    Compositions and methods for improved honey bee health

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  4. US 11623927

    Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules

    The Regents of the University of California · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  5. US 11624125

    Stabilization of colloidal crystals engineered with nucleic acid

    Northwestern University · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  6. US 11622977

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  7. US 11623002

    ALK polypeptides and methods of use thereof

    Elicio Therapeutics, Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  8. US 11623945

    Immunostimulating compositions and uses therefore

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  9. US 11622547

    Genetically modified mouse that expresses human albumin

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  10. US 11623918

    Compounds for the treatment of acute and chronic kidney disease

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  11. US 11623010

    Pharmaceutical carrier in the preparation of an anti-diabetic pharmaceutical composition and methods for treatment

    BEIJING RONGXIANG INSTITUTE OF REGENERATIVE MEDICINE CO., LTD. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  12. US 11623923

    Uracil compound as c-MET/AXL inhibitor

    Medshine Discovery Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  13. US 11622968

    Heterocyclic modulators of lipid synthesis

    Sagimet Biosciences Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  14. US 11622991

    Protocol for treatment of lupus nephritis

    AURINIA PHARMACEUTICALS INC. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  15. US 11623011

    Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

    ENGENE, INC. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  16. US 11623012

    Bicyclic peptide ligands specific for EphA2

    BicycleRD Limited · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  17. US 11623924

    Modulators of alpha-1 antitrypsin

    Vertex Pharmaceuticals Incorporated · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  18. US 11623929

    Spirocyclic compounds

    C4 THERAPEUTICS, INC. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  19. US 11623930

    Imidazodiazepinediones and methods of use thereof

    Goldfinch Bio, Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  20. US 11623932

    Protein degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  21. US 11622933

    Soluble estradiol capsule for vaginal insertion

    Compass Therapeutics LLC · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  22. US 11622970

    BCL-2 inhibitors and their use as pharmaceuticals

    Prelude Therapeutics, Incorporated · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  23. US 11622954

    Estrogen receptor ligands, compositions and methods related thereto

    The Regents of the University of California · Granted Apr 11, 2023 · Expires Apr 6, 2043

    granted

  24. WO 2023054310

    ENSEMBLE DE PERFUSION GOUTTE-À-GOUTTE INTRAVEINEUX POURVU D'UN FILTRE DE PERFUSION À ÉVENT D'AIR

    BASILEA PHARMACEUTICA INT AG ALLSCHWIL [CH] · Granted Apr 6, 2023 · Expires Apr 1, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.